Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment

Folia Med (Plovdiv). 2015 Jul-Dec;57(3-4):261-3. doi: 10.1515/folmed-2015-0048.

Abstract

Lithium is frequently used as a mood stabilizer in patients with mood disorders. Lithium has a narrow therapeutic index and high toxicity. Predisposing factors for intoxication are advanced age, diet disturbances, comorbid medical conditions affecting heart, kidneys or central nervous system and polypharmacy.

Case report: Here we present a case of a 74-year-old woman with a history of Parkinson's disease, hypertension and bipolar disorder. She was using quetiapine, valsartan with hydrochlorothiazide and levodopa with carbidopa. She presented with altered mental status and muscle rigidity. The patient was admitted with acute lithium intoxication after her second dose of treatment. Blood lithium level increased to 3.58 mEq/L. The woman was hospitalized in the Internal Medicine Intensive Care Unit. With hydration, her symptoms resolved and her lithium level returned to normal after 118 hours.

Conclusions: Prescribing physicians and emergency room physicians should be aware of conditions which may cause a decreased threshold for intoxication.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Bipolar Disorder / drug therapy
  • Female
  • Humans
  • Lithium / adverse effects*
  • Lithium / analysis*
  • Lithium / therapeutic use
  • Parkinson Disease
  • Polypharmacy

Substances

  • Antidepressive Agents
  • Lithium